Ledger.Open graph →
SEC Form D · filed July 12, 2016

AnTolRx, Inc

Offering
$4.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Mark Carthy · Boston, MAExec · DirectorSatish Jindal · Cambridge, MADirectorSatish Jindal · Cambridge, MADirectorFrancisco Quintana · Boston, MADirectorFrancisco Quintana · Boston, MADirectorMark Carthy · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗